Eyebright Medical Technology (Beijing) Co., Ltd. (SHA:688050)
50.81
+0.20 (0.40%)
May 8, 2026, 3:00 PM CST
SHA:688050 Revenue
Eyebright Medical Technology (Beijing) had revenue of 398.24M CNY in the quarter ending March 31, 2026, with 11.50% growth. This brings the company's revenue in the last twelve months to 1.52B, up 4.60% year-over-year. In the year 2025, Eyebright Medical Technology (Beijing) had annual revenue of 1.48B with 5.15% growth.
Revenue (ttm)
1.52B
Revenue Growth
+4.60%
P/S Ratio
6.45
Revenue / Employee
664.24K
Employees
2,460
Market Cap
9.83B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.48B | 72.68M | 5.15% |
| Dec 31, 2024 | 1.41B | 458.85M | 48.24% |
| Dec 31, 2023 | 951.18M | 371.68M | 64.14% |
| Dec 31, 2022 | 579.50M | 146.43M | 33.81% |
| Dec 31, 2021 | 433.07M | 160.02M | 58.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Blue Sail Medical | 5.84B |
| Tofflon Science and Technology Group | 5.20B |
| Allmed Medical Products Co.,Ltd | 3.81B |
| Autek China | 1.84B |
| Sansure Biotech | 1.60B |
| Aidite (Qinhuangdao) Technology | 1.09B |
| Mingyue Optical Lens | 863.61M |
| Hubei Huaqiang High-Tech | 666.99M |